期刊文献+

胃肠道间质瘤临床病理分析

Analysis of the clinicopathology and immunohistochemistry on gastrointestinal stromal tumors
下载PDF
导出
摘要 目的探讨胃肠道间质瘤(GIST)的组织病理形态和免疫组织化学特点。方法应用免疫组织化学Supervision^TM法对原发性GIST组织中的CD117、CD34、SMA、desmin、S-100蛋白进行研究。结果本组GIST发病年龄在42—77岁(平均56岁)。男性8例,女性11例。肿瘤组织形态为梭形细胞和上皮样细胞。梭形细胞呈交叉束状、旋涡状、席纹状排列;上皮样细胞多呈弥漫片状或巢状排列。可以伴有囊性变、粘液变、出血及坏死、核分裂象大于或等于5/50HPF的3例中肿瘤直径均大于5cm。免疫组化染色CD117和CD34多为弥漫强阳性,阳性率分别为94.74%和73.68%。SMA不表达或者呈灶性阳性,S-100蛋白和desmin阴性。结论GIST好发生在中老年,肿瘤细胞形态多变,排列方式多样,免疫组织化学染色CD117阳性对诊断有确定作用,CD34表达对诊断也有重要意义。 Aim To study the histopathological and immunohistochemical staining on gastrointestinal stromal tumor(GIST). Methods GIST were performed in the primary gastrointestinal tumors for a panel of antibodies such as CDll7, CD34, SMA, desmin, S-100 protein by supervision^TM. Results The patient's ages ranged from 42 years to 77 years ( mean 56 years), including 8 males and 11 females.The tumor cells consisted of spindle shaped cells and epithelioid cells. The spindle shaped cells arranged in fascicular, whorled, and storiform ; The epithelioid cells arranged in diffusing sheets of " nest" appearance. The mitotic count was higher than 5/50HPF in 3 cases which were over or equal 5cm in diameter, hnmunohistochemically, CD117 and CD34 showed diffuse strong expression. The positive rates were 94.7% and 73.7% respectively. Desmin and S-100 protein were almost never present. SMA was focally present or absent. Conclusions GIST predominantly occurred in middle aged or older patients, with various kinds of cell types and different arrangements. The immunohistochemical characters were positive for CD117 and CD34. CD117 have certain function to the diagnosis, and CD34 also have significance in diagnosis.
出处 《安徽医药》 CAS 2006年第10期765-767,共3页 Anhui Medical and Pharmaceutical Journal
关键词 胃肠道间质瘤 免疫组织化学 病理学 gastrointestinal stromal tumors histopathology immunohistochemistry
  • 相关文献

参考文献13

二级参考文献68

  • 1赵海潞,纪小龙.消化道间叶性肿瘤的新认识[J].新消化病学杂志,1996,4(2):100-101. 被引量:19
  • 2金行藻.胃肠道间质瘤[J].诊断病理学杂志,1996,3(2):108-110. 被引量:25
  • 3[1]Miettinen M, EL-Rifai W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: review [J] .Hum Pathol, 2002,33:478 ~ 83.
  • 4[2]Miettinen M, Lasota J. Gastrointestinal stromal tumor-definition, clinical,histological, immunohistochemical, and molecular genetic features and differential diagnosis[J] .Virchows Arch,2001 ,438:1 ~ 12.
  • 5[3]Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutation of ckit in human gastrointestinal stromal tumors [ J ] .Science, 1998,279(23) :577 ~ 80.
  • 6[4]Heinrich MC,Corless CL,Duensing A,et al.PDGFA activating mutations in gastrointestinal stromal tumors[J] .Science,2003,299:708 ~ 10.
  • 7Miettinen M, Lasota J. Gastrointestinal stromal tumors- definition,clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 2001,438 : 1-12.
  • 8Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology.Hum Pathol, 1999,30 : 1213 -1220.
  • 9Roggen JF, Velthuysen MLFV, Hogendoom PCW. The histopathological differential diagnosis of gastrointestinal stromal tumors.J Clin Pathol, 2001,54:96-103.
  • 10Saul SH, Rast ML, Brooks JJ. The immunohistochemistry of gastrointestinal stromal tumors. Am J Surg Pathol, 1987,11 : 464-473.

共引文献489

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部